CP Plus reports a threefold increase in Q4 PAT to Rs 169 crore, driven by significant revenue growth and expansion plans.

Plus Inc (PLUS) reports robust financial performance with double-digit growth, strategic divestitures, and a focus on AI, despite facing industry challenges.

Welcome to the ePlus Fourth Quarter Fiscal Year 2026 Earnings Results Conference Call. As a reminder, this conference call is being recorded. [Operator Instructions] I would like to introduce your ...

Good morning, ladies and gentlemen. Thank you for standing by, and welcome to 5N Plus Inc. Fourth Quarter 2024 Results Conference Call. At this time note that all participants are in a listen-only ...

Plus Therapeutics, Inc. announced that it will release its fourth quarter and full year 2024 financial results on March 27, 2025, after market close, followed by a conference call at 5:00 p.m. ET to ...